Related Experiment Video
Updated: Jun 10, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Exploring the efficacy and tolerability of two-injection start regimen of long-acting aripiprazole: A descriptive
Ibrahim Sungur1,2, Kaan Keskin1,2, Elif Özge Aktaş1,2
1Department of Psychiatry, Ege University, Izmir, Turkey.
Abstract:
Bipolar disorder is the fourth most debilitating psychiatric illness in the world regarding Disability Adjusted Life Years and manic episodes frequently lead to lengthy hospitalizations which restricts the freedom of patients. Therefore, decreasing the length of hospitalization with safer agents is of utmost importance in the treatment of manic episodes. Aripiprazole is a medication known for its efficacy in managing mania associated with bipolar disorder. Aripiprazole long-acting injection is approved for the treatment of mania associated with bipolar disorder in adults and found efficacious as a maintenance treatment. In the treatment of schizophrenia, European Medicines Agency has approved a simplified starting strategy of aripiprazole once a month, with two 400 mg injections and a single oral 20 mg dose of aripiprazole. To the best of our knowledge, no previous study has reported the safety, tolerability, and efficacy of this regimen in adult bipolar disorder patients. We present a case series of eight patients who were admitted to the hospital in a manic episode with psychotic features. We observed that the double injection start regimen was effective in treating manic symptoms with no specific severe adverse events. We conclude from a small sample of manic patients that a double injection start regimen has good efficacy and tolerability.
Insights
Aripiprazole long-acting injections can effectively treat manic episodes in bipolar disorder patients. This study found a double injection start regimen safe and well-tolerated, potentially reducing hospital stays.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Bipolar disorder is a leading cause of disability worldwide.
- Manic episodes often necessitate lengthy hospitalizations, impacting patient freedom.
- Safer, effective treatments to shorten hospital stays for mania are crucial.
Observation:
- Aripiprazole long-acting injection is approved for bipolar mania and maintenance.
- A simplified starting strategy using two injections and an oral dose is approved for schizophrenia.
- This regimen's safety and efficacy in bipolar disorder were previously unreported.
Findings:
- A case series of eight patients with manic episodes and psychotic features was studied.
- The double injection start regimen demonstrated effectiveness in managing manic symptoms.
- No severe adverse events were observed, indicating good tolerability.
Implications:
- This double injection start regimen shows promise for treating acute manic episodes in bipolar disorder.
- The findings suggest a potential strategy to reduce hospitalization duration.
- Further research with larger samples is warranted to confirm these preliminary results.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Psychosis: Goals of Pharmacotherapy
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents

